Asset sale Announced
SHINE Technologies acquisition of Lantheus SPECT business
Announced Jan 2026 (approx.)
Advisers
SHINE Technologies
Acquirer
Not disclosed
- Target
- Lantheus SPECT business
- Acquirer
- SHINE Technologies
- Seller
- Lantheus
- Target based in
- United States
- Buyer based in
- United States
- Seller based in
- United States
- Sector
- Pharma
- Tags
- Pharma, Radiopharmaceuticals, Diagnostics
In the league tables
Similar deals
- Curium US Holdings acquisition of Lantheus Holdings Aug 2026 · US$8bn · Radiopharmaceuticals
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Gilead acquisition of HCXT-2001 (investigational oral IL-23R inhibitor) Oct 2026 · Pharma
- Labcorp acquisition of Select assets of BioReference Health Oct 2026 · Diagnostics
- US WorldMeds acquisition of Orbus Therapeutics Oct 2026 · Pharma
Sources
- Jan 2026 Solomon Partners: Served as financial advisor to Lantheus on the sale of its SPECT business to SHINE Technologies solomonpartners.com